dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Montes de Oca, Maria |
dc.contributor.author | Lopez Varela, Maria Victorina |
dc.contributor.author | Menezes, Ana M. B. |
dc.contributor.author | Wehrmeister, Fernando C. |
dc.contributor.author | Ramirez, Larissa |
dc.contributor.author | Miravitlles Fernández, Marc |
dc.date.accessioned | 2022-05-13T05:57:58Z |
dc.date.available | 2022-05-13T05:57:58Z |
dc.date.issued | 2021 |
dc.identifier.citation | Montes de Oca M, Lopez Varela MV, Menezes AMB, Wehrmeister FC, Ramirez L, Miravitlles M. Respiratory symptoms (COPD Assessment Test and modified Medical Research Council dyspnea scores) and GOLD-ABCD COPD classification: the LASSYC study. J Bras Pneumol. 2021;47(5):e20210156. |
dc.identifier.issn | 1806-3756 |
dc.identifier.uri | https://hdl.handle.net/11351/7521 |
dc.description | Malaltia pulmonar obstructiva crònica; Símptomes; MPOC |
dc.description.sponsorship | This observational study was funded by AstraZeneca Latin America. The funder had no input into the study design, analysis, or interpretation of the results. |
dc.language.iso | eng |
dc.publisher | Sociedade Brasileira de Pneumologia e Tisiologia |
dc.relation.ispartofseries | Jornal Brasileiro de Pneumologia;47(5) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Qüestionaris |
dc.subject | Pulmons - Malalties obstructives - Diagnòstic |
dc.subject.mesh | Pulmonary Disease, Chronic Obstructive |
dc.subject.mesh | /diagnosis |
dc.subject.mesh | Surveys and Questionnaires |
dc.title | Respiratory symptoms (COPD Assessment Test and modified Medical Research Council dyspnea scores) and GOLD-ABCD COPD classification: the LASSYC study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.36416/1806-3756/e20210156 |
dc.subject.decs | enfermedad pulmonar obstructiva crónica |
dc.subject.decs | /diagnóstico |
dc.subject.decs | encuestas y cuestionarios |
dc.relation.publishversion | https://doi.org/10.36416/1806-3756/e20210156 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Montes de Oca M] Universidad Central de Venezuela, Caracas, Venezuela. [Lopez Varela MV] Universidad de la República, Montevideo, Uruguay. [Menezes AMB, Wehrmeister FC] Programa de Pós-graduação em Epidemiologia, Universidade Federal de Pelotas, Pelotas (RS) Brasil. [Ramirez L] AstraZeneca, Costa Rica. [Miravitlles M] Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER de Enfermedades Respiratorias, Barcelona, Spain |
dc.identifier.pmid | 34787288 |
dc.identifier.wos | 000755715900007 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |